Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies - PubMed (original) (raw)

. 1991 May 15;51(10):2628-35.

Affiliations

PMID: 1673638

Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies

A H Schinkel et al. Cancer Res. 1991.

Abstract

We have cloned a human MDR3 complementary DNA, coding for a P-glycoprotein, into a mammalian expression vector and cotransfected it with a selectable marker into drug-sensitive human BRO melanoma cells. With low frequency we obtained stable, MDR3-expressing clones. Immunocytochemical and immunoblotting analysis of these clones using the monoclonal antibody C219 indicated that human MDR3 P-glycoprotein, like human MDR1 P-glycoprotein, was mainly localized in the plasma membrane and probably glycosylated. Although a significant fraction of the cells (5-10%) in one of the MDR3-expressing clones expressed as much P-glycoprotein as a clearly drug-resistant MDR1-transfected clone, we found no resistance against a range of drugs affected by multidrug resistance. The drugs tested included vincristine, colchicine, VP16-213, daunorubicin, doxorubicin, actinomycin D, and gramicidin D. We did not detect enhanced daunorubicin efflux either in any of the MDR3-expressing cells by fluorescence microscopy. Direct selection with vincristine, actinomycin D, gramicidin D, or daunorubicin of BRO cells transfected with expression constructs containing the regular MDR3 complementary DNA, or a complementary DNA representing a major MDR3 splice variant (C(-141)), likewise failed to yield resistant clones. Thus, although human MDR3 P-glycoprotein is highly similar to human MDR1 P-glycoprotein, we found no indications that it can transport drugs. We investigated the cross-reactivity of the monoclonal antibodies C219, C494, JSB-1, HYB-241, and MRK16, recognizing human MDR1 P-glycoprotein, with human MDR3 P-glycoprotein using immunocytochemistry and immunoblotting. Apart from monoclonal antibody C219, none of the monoclonal antibodies showed detectable cross-reactivity with human MDR3 P-glycoprotein. In our hands, monoclonal antibodies MRK16 and HYB-241 were most suitable for sensitive and specific cytochemical detection of human MDR1 P-glycoprotein.

PubMed Disclaimer

Cited by

Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.
Kenicer J, Spears M, Lyttle N, Taylor KJ, Liao L, Cunningham CA, Lambros M, MacKay A, Yao C, Reis-Filho J, Bartlett JM. Kenicer J, et al. BMC Cancer. 2014 Oct 14;14:762. doi: 10.1186/1471-2407-14-762. BMC Cancer. 2014. PMID: 25312014 Free PMC article.
Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
Mechetner EB, Roninson IB. Mechetner EB, et al. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5824-8. doi: 10.1073/pnas.89.13.5824. Proc Natl Acad Sci U S A. 1992. PMID: 1352877 Free PMC article.
Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas.
Tóth K, Vaughan MM, Slocum HK, Fredericks WJ, Chen YF, Arredondo MA, Harstrick A, Karakousis C, Baker RM, Rustum YM. Tóth K, et al. Am J Pathol. 1992 May;140(5):1009-16. Am J Pathol. 1992. PMID: 1374585 Free PMC article.
Structure of the human lipid exporter ABCB4 in a lipid environment.
Olsen JA, Alam A, Kowal J, Stieger B, Locher KP. Olsen JA, et al. Nat Struct Mol Biol. 2020 Jan;27(1):62-70. doi: 10.1038/s41594-019-0354-3. Epub 2019 Dec 23. Nat Struct Mol Biol. 2020. PMID: 31873305

Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies - PubMed (original) (raw)